To break the pharmaceutical dependence of the United States with the Chinese Communist Party (CCP), the Trump administration provided a loan of $765 million to the Kodak company to produce drugs and raw materials in the United States.

Kodak will receive a multi-million-dollar loan from the federal government as an incentive for the local production of drugs and pharmaceutical raw materials.

The objective is to cut the dependence on foreign pharmaceuticals and generate employment and develop the local industry.

The CCP concentrates the production of more than 80 percent of the medicines consumed in America, and the government loan will help support the initial costs needed to reuse and expand Kodak’s existing facilities in Rochester and St. Paul, Minnesota.

The photo giant’s new diversification is also expected to create more than 300 new jobs.

Kodak Building in Rochester, NY, USA (Viktor Nagornyy/Flickr)

The news was reported Tuesday by White House business advisor Peter Navarro on a FOX Business radio program.

Navarro predicted that this is a starting point for cutting the pharmaceutical dependence that the United States suffers.

According to the commercial advisor, the decision came from President Trump, who signed an executive order with the Development Finance Corporation to find effective ways of financing and to facilitate the production chains that today manufacture outside the country to return to the United States.

Under the old Defense Production Act, the federal government will grant Kodak the sum of $765 million.

Based in Rochester, New York, the company will receive the loan to start producing raw materials and active ingredients for the pharmaceutical industry.

According to the WSJ, among the medicines to be produced is the antimalarial drug hydroxychloroquine which has been singled out as an optimal drug for early treatment of the CCP Virus.

According to Rosemary Gibson of the Hastings Center Bioethics Research Institute, author of the book “China Rx : Exposing the Risks of U.S. Dependence on China for Medicine,” the U.S. pharmaceutical dependence on the CCP is more than alarming.

As Gibson reports in her book, medications manufactured in China include most antibiotics, birth control pills, blood pressure medications such as valsartan, anticoagulants such as heparin, and various anti-cancer drugs.

Also included are such common drugs as penicillin, ascorbic acid (vitamin C), and aspirin.

The list also includes drugs to treat HIV, Alzheimer’s disease, bipolar disorder, schizophrenia, cancer, depression, epilepsy, etc.

A recent Commerce Department study found that 97 percent of all antibiotics in the United States came from China.